Just Diagnosed

You are here

Just Diagnosed

If you have been NEWLY DIAGNOSED  START HERE 

Video Library

Case Based Panel Discussion - Choosing Between Targeted Therapy and Immunotherapy in a Patient with an EGFR Mutation and High PDL-1 Expression
Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss the treatment choice between targeted therapy and immunotherapy in a patient with an EGFR Mutation and high PDL-1.
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapy, General Lung Cancer, Non Small Cell Lung Cancer, Immunotherapies
Case Based Panel Discussion - Metastatic Squamous NSCLC Low Tumor PD-L1 Frail Patient - Treatment?
Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss a frail patient with metastatic squamous NSCLC with low tumor PD-L1 expression, and the best treatment approach for this patient.
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Aging and Elderly, General Lung Cancer, Non Small Cell Lung Cancer, Tumor Marker Tests, Immunotherapies, Chemotherapy
,
,
,
,
Molecular Diagnostics Testing and Next Generation Sequencing
The Global Resource for Advancing Cancer Education (GRACE), presents Molecular Diagnostic Testing and Next Generation Sequencing in Lung Cancer webinar series.
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Molecular Testing
,
,
,
,
2017 Advances in Immunotherapy: What Lung Cancer Patients Need to Know OncTalk
The Global Resource for Advancing Cancer Education (GRACE), in partnership with Georgetown University Hospital is pleased to present the videos from the panel discussion "2017 Advances in Immunotherapy: What Lung Cancer Patients Need to Know".
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Biopsy/Tissue Collection, Tumor Marker Tests, Targeted Therapy, First-line treatment, Clinical Trials, Investigational Agents, Immunotherapies, Second-line treatment
Lung Cancer Video Library - MET as a Target in Advanced NSCLC
Dr. Vamsidhar Velcheti with the Cleveland Clinic joined GRACE to discuss updates to our Lung Cancer Video Library. In this video, Dr. Velcheti discusses MET as a target in advanced non-small cell lung cancer.
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Non Small Cell Lung Cancer, Targeted Therapy

Articles

Head & Neck Cancers - Frequently Asked Questions
Head & Neck Cancers Frequently Asked Questions Written by Joshua Bauml, MD September 2017 What is it? “Head and neck cancer” is an umbrella term...
Cancer Journey:
Just Diagnosed
Cancer Type:
Head and Neck Cancer
Disease Learning:
Head and Neck Cancer
Progress in Understanding DNA Changes in Lymphoma
Malignant Hematology Progress in understanding DNA changes in lymphoma has already provided improved and highly sensitive tests for detecting this...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Blood Cancers
Disease Learning:
Non-Hodgkin Lymphoma, Mantle Cell Lymphoma, General Blood Cancer
My Top 10 ASCO 2017 Lung Cancer Presentations
Over the next few days, about 30,000 oncologists and other cancer care professionals, along with a growing number of patient advocates, are...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Non Small Cell Lung Cancer, Small Cell Lung Cancer
New FDA Approval for Zykadia (ceritinib) for ALK-Positive NSCLC: Why I Think It's a Poor Choice for Initial Treatment
The FDA just approved a new therapy for the approximately 4% of patients with NSCLC who have the molecular marker known as an ALK rearrangement. The...
Cancer Journey:
In Treatment, Just Diagnosed
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapy
Translation of Molecular Genetics in Lung Cancer into Treatment Decision
Christine M. Walko, Pharm.D., discusses how advancements in technology have improved the quality, cost and turnaround time for assessing genetic mutations in tumor tissue, and how this has helped to translate precision medicine into standard clinical practice.
Cancer Journey:
In Treatment, Just Diagnosed
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer

Community Forum

Osimertinib
Mother-in-Law was diagnosed with NSCLC and after a blood biopsy, doctor is recommending Osimertinib. I tried searching on the main page, but it wasn'...
Cancer Journey:
Just Diagnosed
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, Drugs, Targeted Therapies - EGFR, First-line treatment, Non Small Cell Lung Cancer
Get the Latest from GRACE
March 20, 2018 at 2:04 pm #1294118 JimC Forum Moderator JimC Forum Moderator If you’d like to stay informed about the latest GRACE developments, you...
Cancer Journey:
In Remission, In Treatment, Just Diagnosed, Survivorship
Cancer Type:
Lung Cancer, Blood Cancers, Head and Neck Cancer
Disease Learning:
Nodule concern
I’m a 40yr old female with a smoking history of 20+ years. I have chronic brown phlegm (for years) with little to no coughing. I had a chest X-ray in...
Cancer Journey:
Just Diagnosed
Cancer Type:
Lung Cancer
Disease Learning:
Symptoms
Pure GGO repeat scans
Dear Dr. West and other contributing physicians, I am a now 32 year old male. 2 years ago at 30 years of age in early March 2012 a 4mm pure GGO was...
Cancer Journey:
Just Diagnosed
Cancer Type:
Lung Cancer
Disease Learning: